MedPath

Assesment of the body water distribution after esophagectomy using Bioelectrical Impedance Analysis(BIA) device and FloTrac system

Not Applicable
Recruiting
Conditions
Esophageal cancer
Registration Number
JPRN-UMIN000030734
Lead Sponsor
niversity of Tokyo
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
200
Inclusion Criteria

Not provided

Exclusion Criteria

Patients who meets any of the conditions below are excluded from the study. 1) Those under 20 years old. 2) Those with heart pacemakers. 3) Those with preoperatively diagnosed heart failure or respiratory failure. 4) Those who cannnot use electrodes for BIA devices due to allergic reactions or dermatological problems. 5) Those who cannot keep the supine position during the measurements due to psychological or other factors. 6) Those who meet the contraindication criteria described in the manuals of BIA device (MLT-550N) or FloTrac system. 7) Those who have ineligibility judged by the researchers of the study.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Comparison between the estimated dates of the fluid retention by the traditional judging methods(negative water balance in record-based calculation, decrease in body weight) and the date estimated by the peak in each maker of Bioelectrical Impedance Analysis(BIA) measured on admission day and from postoperative 0 to 7days, or of FloTrac systems measured postoperatively.
Secondary Outcome Measures
NameTimeMethod
1) Correlation between the marker trends in BIA or FloTrac system and the trends in blood markers(Hb,Hct,Alb,BUN/Cre,CRP)or urinary osmolarity. 2) Correlation between the postoperative courses (adverse events, length of ICU stay, length of hospital stay) and the levels of BIA or FloTrac markers at postoperative specific timing. 3) Difference in BIA or FloTrac marker peaks among different esophageal surgical procedures.
© Copyright 2025. All Rights Reserved by MedPath